toripalimab-tpzi

CHEBI:CHEBI_753411

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAVENOUS
marketing_category
BLA
marketing_start_date
20231027
package_marketing_start_date
20231027
nui
N0000191259
pharm_class_epc
Programmed Death Receptor-1 Blocking Antibody [EPC]
pharm_class
Programmed Death Receptor-1-directed Antibody Interactions [MoA]
pharm_class_moa
Programmed Death Receptor-1-directed Antibody Interactions [MoA]
generic_name
toripalimab-tpzi
brand_name
LOQTORZI
brand_name_base
LOQTORZI
product_ndc
70114-340
application_number
BLA761240
labeler_name
Coherus BioSciences, Inc.
manufacturer_name
Coherus BioSciences, Inc.
spl_id
eb8f028a-5e93-498e-bfdd-85530ddfe3b0
active_ingredient_name
TORIPALIMAB
active_ingredient_strength
240 mg/6mL
package_ndc
70114-340-01
package_description
1 VIAL, GLASS in 1 CARTON (70114-340-01) / 6 mL in 1 VIAL, GLASS
rxcui
2669420
unii
8JXN261VVA
spl_set_id
82e7921a-1e84-4988-9799-0ad7d19b2a75
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class